Back to Results
First PageMeta Content
Ribbon symbolism / Oncology / Adjuvant therapy / Breast cancer / Tamoxifen / Trastuzumab / Exemestane / Chemotherapy / Oncotype DX / Medicine / Cancer treatments / Aromatase inhibitors


GERIATRIC THERAPEUTICS Editors: Michael Woodward, Director, Aged and Residential Care Services, Stephen Campbell, Consultant Geriatrician, Rohan Elliott, Clinical Pharmacist, Graeme Vernon, Drug Information Pharmacist, F
Add to Reading List

Document Date: 2008-06-23 23:54:54


Open Document

File Size: 413,04 KB

Share Result on Facebook

City

San Antonio / Austin / Oxford / Victoria / /

Company

Fleming / Level I / Intergroup / Breast Cancer International Research Group / /

Country

Netherlands / /

/

Facility

Austin Hospital / Memorial Sloan-Kettering Cancer Center / Pharmacy Practice / /

IndustryTerm

therapies for breast cancer / treatment of oestrogen receptor positive disease / treatment for early-stage breast cancer / oncological tool / breast cancer therapy / treatment algorithms / technology assessment / therapy for women with early breast cancer / treatment of oestrogen receptor positive early breast cancer / therapy for women with breast cancer / comorbidity management / /

MedicalCondition

hormone receptorpositive breast cancer / oestrogen receptor negative disease / advanced disease / node-positive breast cancer / uterine cancer / vascular disease / psychosexual and cognitive dysfunction / operable / node-positive breast cancer / operable HER2-positive breast cancer / advanced colorectal cancer / myelodysplastic syndrome / early breast cancer / acute myelogenous leukaemia quoted risks / J Cancer / peripheral neuropathy / Vlastos G. Older female cancer / febrile neutropenia / cardiac dysfunction / primary cancer / chronic hormone therapy / e.g. stomatitis / receptor-positive breast cancer / aggressive cancer / oestrogen receptor positive disease / illness / MS / breast cancer / adjuvant breast cancer / osteopenia / congestive heart failure / early-stage breast cancer / cancer / hormone receptor-negative breast cancer / positive early breast cancer / arthralgia / early and advanced breast cancer / emphysema / III breast cancer / chronic illness / tumour / older cancer / bone metastases / diabetes mellitus / heart failure / acute myelogenous leukaemia / early-stage breast cancer receiving adjuvant chemotherapy / osteoporosis / micrometastatic disease / chronic medical conditions / infection / elderly cancer / HER2-positive breast cancer / lymph node-negative breast cancer / Acute myeloid leukemia / /

MedicalTreatment

Polychemotherapy / adjuvant chemotherapy / breast cancer therapy / chemotherapy / radiotherapy / hormone therapy / biological therapy / adjuvant radiotherapy / Adjuvant Therapy / /

NaturalFeature

Fleming MT / /

Organization

Natl Med Assoc / Austin Hospital / American Society of Clinical Oncology / Memorial Sloan-Kettering Cancer Center / Department of Medical Oncology / Joint Ludwig-Austin Oncology Unit / /

Person

Shane White / Francine Tanner / Peter Ravdin / Rohan Elliott / Graeme Vernon / Stephen Campbell / Josephine M Stewart / Robyn Saunders / Michael Woodward / /

Position

Prime Minister / Drug Information Pharmacist / Muss HB / physician / researcher / Consultant / Muss HB / et al / Director / Fisher / Consultant Pharmacist / Victoria / Clinical Pharmacist / Consultant Pharmacist / /

Product

carboplatin / cyclophosphamide / exemestane / vitamin D / ACTH / anastrozole / letrozole / paclitaxel / testosterone / Arimidex / /

ProvinceOrState

Texas / /

Technology

Oncology technology / gene amplification / antibodies / pharmacokinetics / chemotherapy / treating cancer / treatment algorithms / /

SocialTag